Skip to content
10-K

Annual Report

Caribou Biosciences, Inc. CRBU

0001619856-26-000008

← back to feed
Filed
Mar 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 27, 2026 96.64M sh
Shares Diluted FY 2025 · Dec 31, 2025 93.39M sh
Shares Diluted FY 2025 · Dec 31, 2024 90.32M sh
Capex FY 2025 · Dec 31, 2025 $1.36M
Capex FY 2025 · Dec 31, 2024 $4.88M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$110.99M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$138.2M
Cash And Equivalents FY 2025 · Dec 31, 2025 $12.36M
Cash And Equivalents FY 2025 · Dec 31, 2024 $16.29M
Stockholders Equity FY 2025 · Dec 31, 2025 $122.18M
Stockholders Equity FY 2025 · Dec 31, 2024 $252.95M
Stockholders Equity FY 2025 · Dec 31, 2023 $368.4M
Current Liabilities FY 2025 · Dec 31, 2025 $25.41M
Current Liabilities FY 2025 · Dec 31, 2024 $30.65M
Total Liabilities FY 2025 · Dec 31, 2025 $53.19M
Total Liabilities FY 2025 · Dec 31, 2024 $60.36M
Current Assets FY 2025 · Dec 31, 2025 $145.23M
Current Assets FY 2025 · Dec 31, 2024 $219.38M
Total Assets FY 2025 · Dec 31, 2025 $175.37M
Total Assets FY 2025 · Dec 31, 2024 $313.31M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.59
Eps Diluted FY 2025 · Dec 31, 2024 −$1.65
Eps Basic FY 2025 · Dec 31, 2025 −$1.59
Eps Basic FY 2025 · Dec 31, 2024 −$1.65
Sga Expense FY 2025 · Dec 31, 2025 $37.91M
Sga Expense FY 2025 · Dec 31, 2024 $46.46M
Rd Expense FY 2025 · Dec 31, 2025 $109.44M
Rd Expense FY 2025 · Dec 31, 2024 $130.15M
Net Income FY 2025 · Dec 31, 2025 −$148.13M
Net Income FY 2025 · Dec 31, 2024 −$149.11M
Operating Income FY 2025 · Dec 31, 2025 −$148.34M
Operating Income FY 2025 · Dec 31, 2024 −$166.62M
Revenue FY 2025 · Dec 31, 2025 $11.16M
Revenue FY 2025 · Dec 31, 2024 $9.99M